共 292 条
[1]
Siegel RL(2017)Cancer statistics, 2017 CA Cancer J Clin 67 7-30
[2]
Miller KD(2014)Endometrial carcinoma in high-risk populations: is it time to consider a screening policy? Cytopathology 25 71-77
[3]
Jemal A(2016)International collaboration to harmonise O, et al. diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis BJOG 123 1761-1768
[4]
Fambrini M(2015)Preoperative serum CA125: a useful marker for surgical management of endometrial cancer BMC Cancer 15 396-556
[5]
Sorbi F(2013)The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas Oncology. 27 548-53
[6]
Sisti G(2010)Serum tumour markers in gynaecological cancers Maturitas. 67 46-1985
[7]
Cioni R(2016)Serum human epididymis protein 4 vs. carbohydrate antigen 125 and their combination for endometrial cancer diagnosis: a meta-analysis Eur Rev Med Pharmacol Sci 20 1974-148
[8]
Turrini I(2012)Human epididymis protein 4 reference limits and natural variation in a Nordic reference population Tumour Biol 33 141-4783
[9]
Taddei G(2010)HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer Anticancer Res 30 4779-2188
[10]
Hirsch M(2012)Human epididymis protein 4 (HE4) in benign and malignant diseases Clin Chem Lab Med 50 2181-30